Literature DB >> 18595773

Ligation-mediated amplification for effective rapid determination of viral RNA sequences (RDV).

Shumpei Watanabe1, Tetsuya Mizutani, Kouji Sakai, Kentaro Kato, Yukinobu Tohya, Shuetsu Fukushi, Masayuki Saijo, Yasuhiro Yoshikawa, Ichiro Kurane, Shigeru Morikawa, Hiroomi Akashi.   

Abstract

BACKGROUND: Emerging infectious diseases pose a significant risk to public health. Methods for rapid detection of pathogens are needed to effectively treat these diseases. Recently, we developed new methods for the rapid determination of viral RNA sequences, RDV ver1.0 and ver2.0. We demonstrated that these methods were able to simultaneously detect cDNA fragments of many different viruses without using sequence specific primers. However, some species of viruses, including the Yokose virus (YOKV), a flavivirus, could not be detected using the conventional procedures.
OBJECTIVE: The RDV method was further modified to reduce the candidate PCR primer sets. STUDY
DESIGN: Primer sets were reduced to 256 sets in the improved RDV ver3.0, and theoretically, all viral cDNA fragments ligated by two kinds of adaptors after digestion by two restriction enzymes could be amplified in the PCR step for direct sequencing.
RESULTS: We succeeded in obtaining 118 YOKV cDNA fragments of the 141 sequence fragments. The cDNA fragments covered diverse range of viral genome.
CONCLUSION: We were able to reduce the combinations of PCR primer sets used in the RDV method. This RDV method ver3.0 has a potential to detect viral cDNA fragments of both known and unknown RNA viruses rapidly and conveniently.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18595773      PMCID: PMC7108420          DOI: 10.1016/j.jcv.2008.05.004

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


Introduction

Recently, we developed a method for sequence-independent detection of RNA viruses, the “rapid determination of RNA virus (RDV) method” (Mizutani et al., 2007). In the RDV method, viral genome sequences are obtained without sub-cloning into plasmid vectors. Nucleic acid sequences of severe acute respiratory syndrome coronavirus, murine hepatitis virus, West Nile virus, Japanese encephalitis virus, and Dengue virus were successfully detected in culture supernatants from virus-infected cells by RDV ver1.0, which is our original method for detecting RNA viral genomes (Mizutani et al., 2007, Kihara et al., 2007). To increase sensitivity over RDV ver1.0, the sequence-independent amplification step was improved. By using the improved method, RDV ver2.0, avian paramyxovirus was detected in the allantoic fluid of embryonated chicken eggs (Sakai et al., 2007). A new adenovirus was successfully detected in the culture supernatant of primary kidney cells originating from a fruit bat using this RDV method (RDV-D) (Maeda et al., 2008). RDV methods have the potential to become standard methods for the detection of both known as well as newly emerging unknown viruses in humans and animals. For direct sequencing after amplification of cDNAs in RDV ver1.0 and ver2.0, we use specially designed primer sets in which 6 nucleotides consisting of the CC (HaeIII-digested sequence) and four variable nucleotides are added to the 3′ end of the adapter sequence. Therefore, very large numbers of combinations of primer sets (44  × 44  = 65,536 sets) are theoretically necessary to detect all the viral genomes in a sequence-independent manner (Mizutani et al., 2007). To avoid this level of complexity, we conventionally used the primer sets fixed the 5′ end of two nucleotides in the four variable nucleotide region to AG for the forward primer or GG for the reverse primer. However, we found that some viral species are difficult to detect using the limited combinations of primer sets. For example, the Yokose virus (YOKV) was isolated from a bat in Japan in 1971, and it was found to be an Entebbe bat virus, genus Flavivirus, in the family Flaviviridae. Although the full genome sequence has been published recently (AB114858), little is yet known about the characteristics of the virus (Tajima et al., 2005). We attempted to detect the YOKV sequence in the culture supernatant from virus-infected Vero cells using the procedure of RDV ver1.0 and ver2.0, but this failed. Therefore, in this study, we further improved the RDV method to detect more virus species, in particular by modifying the adaptor ligation step, to reduce the candidates of PCR primer sets for direct sequencing. This RDV ver3.0 was able to detect over 100 cDNA fragments of YOKV.

Methods

Cells and virus

Vero cells were maintained in Dulbecco's modified Eagle's medium with 5% fetal calf serum, penicillin, and streptomycin. The Oita-36 strain of YOKV was kindly provided by Dr. Tomohiko Takasaki (National Institute of Infectious Diseases of Japan). The virus was propagated in Vero cells. At 2 days post-infection, the infectious fluid was harvested. Cellular debris was removed by low-speed centrifugation (2000 ×  g, 15 min, 4 °C) and the resulting supernatant was collected.

Design and scheme of RDV ver3.0

The RDV ver3.0 method includes the four procedures described below (Fig. 1 ).
Fig. 1

Overall scheme for RDV ver3.0. WTA, whole transcriptome amplification; (†) with specially designed primer sets as shown in Fig. 2B.

Overall scheme for RDV ver3.0. WTA, whole transcriptome amplification; (†) with specially designed primer sets as shown in Fig. 2B.
Fig. 2

The design of adaptors and primer sets used in RDV ver3.0. (A) Adaptor-Sse83871 contains sticky-end structures digested with Sau3AI, whereas Adaptor-NotI contains blunt-end structures digested with HaeIII. (B) All primers used in RDV ver3.0. Bold letters indicate 2-variable nucleotides.

RNA extraction

Viral RNA was extracted from the infectious supernatant containing 105.5 TCID50 of viruses by using a Total RNA isolation mini kit (Agilent Technology, USA) in accordance with the manufacture's instruction.

Construction of first cDNA library

A whole transcriptome amplification system (WTA; Sigma–Aldrich, Saint Louis, MO, USA) was used to amplify viral double-stranded cDNA in accordance with the manufacture's instruction. PCR was performed as described in previous paper (Mizutani et al., 2007).

Second cDNA library

After the first cDNA library purification using the MonoFas DNA isolation system (GL Science, Japan), DNA was digested with 40 U of HaeIII (Takara Bio Inc., Japan) and Sau3AI (Takara Bio Inc.) at 37 °C for 30 min, and then the digested DNA was again purified using MonoFas. For construction of the second cDNA library, 2.5 μl of DNA solution, 2.5 μl of distilled water, 2.5 μl of sticky-ended adaptor, Adaptor-Sse83871 (10 μM) and blunt-ended adaptor, Adaptor-NotI (10 μM) were mixed (Fig. 2A). Ligation-convenience kit (Nippon Gene, Japan) was used for adaptor ligation. The DNA solution and 10 μl of ligation mix were reacted at 16 °C for 30 min, and the DNA was isolated using MonoFas. The second cDNA library was amplified by PCR using specially designed primer sets, and the forward primers in which six nucleotides included GATC (Sau3AI-digested sequence) and two variable nucleotides were added to the 3′ end of the Adaptor-Sse83871 sequence, and the reverse primers in which four nucleotides included CC (HaeIII-digested sequence) and two variable nucleotides were added to the 3′ end of the Adaptor-NotI sequence (Fig. 2B). PCR was performed as described in Sakai et al. (2007). The design of adaptors and primer sets used in RDV ver3.0. (A) Adaptor-Sse83871 contains sticky-end structures digested with Sau3AI, whereas Adaptor-NotI contains blunt-end structures digested with HaeIII. (B) All primers used in RDV ver3.0. Bold letters indicate 2-variable nucleotides.

Direct sequencing

After electrophoresis of PCR products on agarose gels, the bands over 150 bp in length were excised, and DNA was extracted from the gel using the MonoFas. Direct sequencing was performed using the forward or reverse primer.

Results

In RDV method ver3.0, different adaptors were ligated at the 5′ and 3′ end of viral dsDNA. The ligation enzyme was changed to the ligation mix in the Ligation-convenience kit (Nippon gene) because this increased the efficacy of ligation (data not shown). The S1–S16 forward primers and N1–N16 reverse primers were used in the second cDNA amplification step for direct sequencing (Fig. 2B). Using the RDV ver3.0, we successfully identified West Nile virus and Dengue virus type 2, which were used in previous our study (Mizutani et al., 2007) (data not shown). The RDV ver3.0 method was performed using extracted RNA from the culture supernatant obtained from YOKV-infected Vero cells. The 256 PCR products were processed by agarose gel electrophoresis. A total of 141 fragments were sequenced by the direct sequencing method, but sequences of 10 fragments were not obtained. One hundred eighteen exhibited high degrees of homology with the nucleic acid sequence of YOKV. Twenty-two DNA fragments were identified as mammal ribosomal RNAs (data not shown). The locations of the PCR fragments found in the YOKV genome are shown in Fig. 3 . From the complete nucleotide sequences of YOKV, there are 10 cDNA fragments over 150 bp with HaeIII- and Sau3AI-digested ends (Fig. 3 column A), which are expected to be detected using RDV ver3.0, and eight fragments were detected (Table 1 and Fig. 3 column B). Nine were obtained as partial digested viral cDNA fragments by HaeIII or Sau3AI (Fig. 3 column C). In addition, we found two or three ligated viral cDNA fragments (Fig. 3 column D) and cDNA fragments not containing recognition sequences of restriction enzymes at the ends (Fig. 3 column E). The limit of detection of RDV ver3.0 was approximate 104 copies of viral genomic RNA as a starting material when using YOKV (data not shown).
Fig. 3

Location of viral cDNA fragments on YOKV genome amplified using the RDV ver3.0. Column A shows 10 cDNA fragments expected to be detected in RDV ver3.0 (over 150 bp cDNA fegments digested by Sau3AI and HaeIII). Columns B–E show YOKV cDNA fragments detected in RDV ver3.0. Column B shows 8 of 10 cDNA fragments as shown in A. Column C shows cDNA fragments partially digested with HaeIII or Sau3AI. These cDNA fragments contained undigested sequences by the restriction enzymes. Column D shows amplicons detected as 2 or 3 ligated cDNA fragments. Column E shows cDNA fragments not containing recognition sequences of restriction enzymes at the ends.

Table 1

Number of sequence DNA fragments detected in RDV ver3.0

Forward primerNumber of sequence DNA fragmentNumber of expected DNA fragment
S111/11 (100) a2 (2) b
S221/21 (100)2 (2)
S33/3 (100)0 (0)
S45/8 (62.5)0 (0)
S511/11 (100)2 (2)
S618/18 (100)1 (1)
S71/3 (33.3)0 (1)
S88/11 (72.7)0 (1)
S911/11 (100)0 (0)
S1011/16 (68.7)0 (0)
S115/6 (83.3)0 (0)
S123/6 (84.17)0 (0)
S134/6 (66.6)1 (1)
S140/00 (0)
S150/1 (0)0 (0)
S165/12 (41.6)0 (0)



Total118/141 (83.6)8 (10)

Number of YOKV cDNA fragments/number of sequence DNA fragments (percent).

Number of detected YOKV cDNA fragments of (number of YOKV cDNA fragments expected to be detected from complete nucleotide sequence).

Location of viral cDNA fragments on YOKV genome amplified using the RDV ver3.0. Column A shows 10 cDNA fragments expected to be detected in RDV ver3.0 (over 150 bp cDNA fegments digested by Sau3AI and HaeIII). Columns B–E show YOKV cDNA fragments detected in RDV ver3.0. Column B shows 8 of 10 cDNA fragments as shown in A. Column C shows cDNA fragments partially digested with HaeIII or Sau3AI. These cDNA fragments contained undigested sequences by the restriction enzymes. Column D shows amplicons detected as 2 or 3 ligated cDNA fragments. Column E shows cDNA fragments not containing recognition sequences of restriction enzymes at the ends. Number of sequence DNA fragments detected in RDV ver3.0 Number of YOKV cDNA fragments/number of sequence DNA fragments (percent). Number of detected YOKV cDNA fragments of (number of YOKV cDNA fragments expected to be detected from complete nucleotide sequence).

Discussion

In this study, we succeeded in reducing the candidates of PCR primer sets for direct sequencing by improving the adaptor ligation step in RDV method. Theoretically, by using all combinations of the S1–S16 forward and N1–N16 reverse primers, all viral cDNA fragments ligated by two kinds of adaptors could be amplified in the direct sequencing step. Therefore, our newly developed RDV ver3.0 has been demonstrated to be superior in detecting unidentified viruses within at most 256 PCR reactions. After direct sequencing, we found that viral DNA fragments could be amplified by PCR with a primer set in which one of two variable nucleotides in forward or reverse primers are matched to the target fragment. We obtained amplicons containing two or three ligated DNA fragments and also obtained viral DNA fragments partially digested with HaeIII or Sau3AI (Fig. 3). As shown in Fig. 3, many DNA fragments, covering a diverse range of viral nucleotide sequences, were detected. This suggests that the sequenced fragments detected by RDV ver3.0 can be used for the design of primers to determine complete viral nucleotide sequences for long PCR when unknown viruses are detected. In this study, we were able to reduce the combinations of PCR primer sets used in the RDV method to a very large degree. This RDV method ver3.0 promises to greatly improve sequence-independent detection of RNA viruses especially when emerging virus disease occurs.
  5 in total

1.  An improved procedure for rapid determination of viral RNA sequences of avian RNA viruses.

Authors:  K Sakai; T Mizutani; S Fukushi; M Saijo; D Endoh; I Kurane; K Takehara; S Morikawa
Journal:  Arch Virol       Date:  2007-06-01       Impact factor: 2.574

2.  Rapid determination of viral RNA sequences in mosquitoes collected in the field.

Authors:  Yuki Kihara; Tomomitsu Satho; Yuki Eshita; Kouji Sakai; Akira Kotaki; Tomohiko Takasaki; Yupha Rongsriyam; Narumon Komalamisra; Raweewan Srisawat; Parichat Lapcharoen; Suchada Sumroiphon; Shiroh Iwanaga; Hiroshi Ushijima; Daiji Endoh; Takeshi Miyata; Akira Sakata; Nobuhiro Kashige; Fumio Miake; Shuetsu Fukushi; Masayuki Saijo; Ichiro Kurane; Shigeru Morikawa; Tetsuya Mizutani
Journal:  J Virol Methods       Date:  2007-09-17       Impact factor: 2.014

3.  Genetic characterization of Yokose virus, a flavivirus isolated from the bat in Japan.

Authors:  Shigeru Tajima; Tomohiko Takasaki; Shigeo Matsuno; Mikio Nakayama; Ichiro Kurane
Journal:  Virology       Date:  2005-02-05       Impact factor: 3.616

4.  Isolation of novel adenovirus from fruit bat (Pteropus dasymallus yayeyamae).

Authors:  Ken Maeda; Eiichi Hondo; Junpei Terakawa; Yasuo Kiso; Numekazu Nakaichi; Daiji Endoh; Kouji Sakai; Shigeru Morikawa; Tetsuya Mizutani
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

5.  Rapid genome sequencing of RNA viruses.

Authors:  Tetsuya Mizutani; Daiji Endoh; Michiko Okamoto; Kazuya Shirato; Hiroyuki Shimizu; Minetaro Arita; Shuetsu Fukushi; Masayuki Saijo; Kouji Sakai; Chang Kweng Lim; Mikako Ito; Reiko Nerome; Tomohiko Takasaki; Koji Ishii; Tetsuro Suzuki; Ichiro Kurane; Shigeru Morikawa; Hidekazu Nishimura
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

  5 in total
  7 in total

Review 1.  From orphan virus to pathogen: the path to the clinical lab.

Authors:  Linlin Li; Eric Delwart
Journal:  Curr Opin Virol       Date:  2011-10       Impact factor: 7.090

2.  A novel sapelovirus-like virus isolation from wild boar.

Authors:  Masako Abe; Naoto Ito; Kouji Sakai; Yoshihiro Kaku; Mami Oba; Miho Nishimura; Ichiro Kurane; Masayuki Saijo; Shigeru Morikawa; Makoto Sugiyama; Tetsuya Mizutani
Journal:  Virus Genes       Date:  2011-06-04       Impact factor: 2.332

3.  Novel betaherpesvirus in bats.

Authors:  Shumpei Watanabe; Ken Maeda; Kazuo Suzuki; Naoya Ueda; Koichiro Iha; Satoshi Taniguchi; Hiroshi Shimoda; Kentaro Kato; Yasuhiro Yoshikawa; Shigeru Morikawa; Ichiro Kurane; Hiroomi Akashi; Tetsuya Mizutani
Journal:  Emerg Infect Dis       Date:  2010-06       Impact factor: 6.883

4.  Direct metagenomic detection of viral pathogens in nasal and fecal specimens using an unbiased high-throughput sequencing approach.

Authors:  Shota Nakamura; Cheng-Song Yang; Naomi Sakon; Mayo Ueda; Takahiro Tougan; Akifumi Yamashita; Naohisa Goto; Kazuo Takahashi; Teruo Yasunaga; Kazuyoshi Ikuta; Tetsuya Mizutani; Yoshiko Okamoto; Michihira Tagami; Ryoji Morita; Norihiro Maeda; Jun Kawai; Yoshihide Hayashizaki; Yoshiyuki Nagai; Toshihiro Horii; Tetsuya Iida; Takaaki Nakaya
Journal:  PLoS One       Date:  2009-01-19       Impact factor: 3.240

5.  Detection of bovine group a rotavirus using rapid antigen detection kits, rt-PCR and next-generation DNA sequencing.

Authors:  Fujiko Minami-Fukuda; Makoto Nagai; Hikaru Takai; Toshiaki Murakami; Tadashi Ozawa; Shinobu Tsuchiaka; Sachiko Okazaki; Yukie Katayama; Mami Oba; Naomi Nishiura; Yukiko Sassa; Tsutomu Omatsu; Tetsuya Furuya; Satoshi Koyama; Junsuke Shirai; Hiroshi Tsunemitsu; Yoshiki Fujii; Kazuhiko Katayama; Tetsuya Mizutani
Journal:  J Vet Med Sci       Date:  2013-08-02       Impact factor: 1.267

6.  Imported case of acute respiratory tract infection associated with a member of species nelson bay orthoreovirus.

Authors:  Atsushi Yamanaka; Akira Iwakiri; Tomoki Yoshikawa; Kouji Sakai; Harpal Singh; Daisuke Himeji; Ikuo Kikuchi; Akira Ueda; Seigo Yamamoto; Miho Miura; Yoko Shioyama; Kimiko Kawano; Tokiko Nagaishi; Minako Saito; Masumi Minomo; Naoyasu Iwamoto; Yoshio Hidaka; Hirotoshi Sohma; Takeshi Kobayashi; Yuta Kanai; Takehiro Kawagishi; Noriyo Nagata; Shuetsu Fukushi; Tetsuya Mizutani; Hideki Tani; Satoshi Taniguchi; Aiko Fukuma; Masayuki Shimojima; Ichiro Kurane; Tsutomu Kageyama; Takato Odagiri; Masayuki Saijo; Shigeru Morikawa
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

7.  Detection of a new bat gammaherpesvirus in the Philippines.

Authors:  Shumpei Watanabe; Naoya Ueda; Koichiro Iha; Joseph S Masangkay; Hikaru Fujii; Phillip Alviola; Tetsuya Mizutani; Ken Maeda; Daisuke Yamane; Azab Walid; Kentaro Kato; Shigeru Kyuwa; Yukinobu Tohya; Yasuhiro Yoshikawa; Hiroomi Akashi
Journal:  Virus Genes       Date:  2009-05-19       Impact factor: 2.332

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.